Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions

Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry, announced that it has acquired Fusion Biotec (Fusion), a design and engineering leader for complex electro-mechanical diagnostic instrumentation and medical devices located in Orange, California. Veranex and Fusion’s combined expertise and specialization in design and engineering, with Veranex’s established infrastructure and expertise for full-scale, rapid development of diagnostic and IVD solutions and Fusion’s ultra-quick concept-to-production model, ensures a continued focus on accelerating the development of diagnostic and medical technology solutions for regulatory and commercial success.

“The COVID pandemic has underscored the need for more affordable and reliable rapid diagnostic testing on a massive scale as well as the need for testing closer to the patient,” said Veranex CEO Tom Daulton. “Fusion’s similar methodologies and expertise fits seamlessly into Veranex’s robust Product Design & Engineering solutions group, which has multifaceted capabilities, including diagnostic devices, IVD, and life science development, regulatory, quality and marketing expertise as well as FDA-regulated manufacturing support — all essential for bringing novel diagnostic technology to the market.”

Recommended AI News: Next-Gen IDP Company AYR joins BNY Mellon’s Accelerator Program to Improve the World of Work

Fusion’s 15,000-square-foot facility in Orange, California, and 45+ in-house team of engineering experts largely serve medical device and life sciences clients in rapidly developing end-to-end diagnostic instrumentation and help extend reach to the Southern California life sciences market. With Veranex, this creates a footprint for product design engineering services across the U.S., with combined company offices now in the Eastern, Central, and Western regions, as well as market access and regulatory, quality, and clinical expertise throughout Veranex’s global operations.

Recommended AI News: D-ID launches First-Ever Generative AI to Combine Text-Image-Video on One Platform

“In addition to specializations in design and engineering, Fusion also has proprietary software and firmware that gives clients a jump-start in development, building off functional prototypes where a high percentage of the design can use pre-developed technology,” said Fusion CEO Bruce Sargeant. “This means projects are customized but do not need to start from scratch each time; thus, prototypes can be feasible in weeks or months, saving time and money. Veranex has similar strengths, a shared focus on design excellence and above all, both companies value human-centered design — we care about incorporating user needs into elegant and very functional medical devices and are committed to continue developing critical diagnostic solutions.”

Recommended AI News: Loftware Achieves Zebra Technologies Validation

[To share your insights with us, please write to sghosh@martechseries.com]

The post Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions appeared first on AiThority.

manufacturing
medical
life sciences
diagnostic
device
devices
ai
software
fda